Elevated levels of antibodies against coatomer protein complex subunit epsilon (COPE) and DAN family BMP antagonist (NBL1) have been suggested to contribute to a high risk of cardiovascular events in patients with obstructive sleep apnea [10, 11]. This evidence concerns the gene NBL1 and obstructive sleep apnea syndrome.